Clinical Trial: Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962813) titled 'Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias' on April 30.

Brief Summary: This study tested V Eraser, Transdermal radiofrequency versus polidocanol sclerotherapy for the treatment of reticular veins and telangiectasia of the legs

Study Start Date: Jan. 10, 2023

Study Type: INTERVENTIONAL

Condition: Varicose Veins Leg Telangiectasias

Intervention: PROCEDURE: Radiofrequency V Eraser

standar of care sclerotherapy

Recruitment Status: COMPLETED

Sponsor: Science Valley Research Institute

Information provided by (Responsible Party): Eduardo Ramacciotti, Science Valley ...